...
首页> 外文期刊>Hemodialysis international >Heparin-induced thrombocytopenia in a hemodialysis patient treated with fondaparinux: Nephrologists between two fires
【24h】

Heparin-induced thrombocytopenia in a hemodialysis patient treated with fondaparinux: Nephrologists between two fires

机译:磺达肝癸钠治疗的血液透析患者的肝素诱导的血小板减少症:两次大火之间的肾脏科医生

获取原文
获取原文并翻译 | 示例
           

摘要

Heparin-induced thrombocytopenia (HIT) is caused by heparin exposure and presents with reduced platelet count. Patients undergoing hemodialysis (HD) treatment have increased risk of developing HIT due to prolonged exposure to unfractionated heparin or low-molecular weight heparin. We report a 79-year-old male patient with end-stage renal disease who developed type-II HIT during maintenance HD. Platelet count of the patient decreased gradually and antiplatelet factor IV antibody was found to be positive. The patient was treated with fondaparinux and continued heparin-free HD. Unfortunately, despite favorable initial response without any thrombotic episodes, the patient died due to severe sepsis complicated by gastrointestinal hemorrhage. Hemodialysis International
机译:肝素诱导的血小板减少症(HIT)是由肝素暴露引起的,并且血小板计数降低。由于长期暴露于普通肝素或低分子量肝素中,接受血液透析(HD)治疗的患者发生HIT的风险增加。我们报告了一名79岁的终末期肾脏疾病的男性患者,他在维持HD​​期间发生II型HIT。患者的血小板计数逐渐降低,发现抗血小板因子IV抗体为阳性。该患者接受磺达肝癸钠治疗并持续无肝素HD。不幸的是,尽管初始反应良好,没有任何血栓形成事件,但患者因严重脓毒症并发消化道出血而死亡。血液透析国际

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号